Autolus reports Q1 2024 Financial Results | Company Announce

Investegate announcements from Autolus reports Q1 2024 Financial Results

Related Keywords

United Kingdom , London , City Of , United States , Stevenage , Hertfordshire , American , Susana Noonan , Johnh Johnson , Ben Atwell Tim Stamper , June Dec , Collins Fergus Witt , Julia Wilson , Ravi Rao , Olivia Manser , Syncona Ltd , Nasdaq , American Society Of Clinical Oncology , Nature Communications , University College London , Exchange Commission , European Medicines Agency , European Hematology Association , Ferrari , Cardinal Health , Sa Noonan Communications , Autolus Therapeutics , Market Authorization Application , Syncona Limited , Therapeutics Reports First Quarter , Lupus Erythematosus , Christian Itin , Chief Executive Officer , Systemic Lupus Erythematosus , B Cell Acute Lymphoblastic Leukemia , Obe Cel Biologics License Application , American Society , Clinical Oncology , Importation Authorization , Marketing Authorization Application , Mike Bonney , Non Executive Director , Structure Guided Engineering , Nat Commun , Blood Cancer Journal , Dualt Cell , Blood Cancer , News Flow , Quarter Ended March , Unaudited Condensed Consolidated Statements , Comprehensive Loss , Months Ended March , Private Securities Litigation Reform Act , Autolu Annual Report ,